Andreas H. Scheel

Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas

Andreas H. Scheel, Manfred Dietel, Lukas C. Heukamp et al. · Modern Pathology · 2016 · 350 citations · Full text

Medicine, Cell Biology, Oncology +10

Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors

Sandra Ortiz‐Cuaran, Matthias Scheffler, Dennis Plenker et al. · Clinical Cancer Research · 2016 · 261 citations · Full text

Medicine, Oncology, Pharmacology +17

K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic Pathways

Matthias Scheffler, Michaela A. Ihle, Rebecca Hein et al. · Journal of Thoracic Oncology · 2018 · 259 citations · Full text

Medicine, Genetics, Oncology +17

PD-L1 expression in small cell neuroendocrine carcinomas

Anne M. Schultheis, Andreas H. Scheel, Luka Ozretić et al. · European Journal of Cancer · 2015 · 237 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Overcoming EGFRG724S-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors

Jana Fassunke, Fabienne Müller, Marina Keul et al. · Nature Communications · 2018 · 139 citations · Full text

Medicine, Oncology, Pharmacology +15